Diabetes Increases Risk of Invasive Aspergillosis in ICU Patients: Study Jacinthlyn Sylvia3 Feb 2025 2:00 AMA systematic review and meta-analysis revealed a significant association between diabetes mellitus (DM) and invasive aspergillosis (IA) among...
RT PCR can help in Early Detection of Triazole-Resistant Aspergillosis Jacinthlyn Sylvia21 July 2023 2:30 PMInvasive aspergillosis (IA) caused by triazole-resistant Aspergillus fumigatus has long been associated with high mortality rates. However, a...
Biocon recalls over 3000 bottles of antifungal drug Posaconazole Delayed Release in US Ruchika Sharma19 Feb 2023 5:45 AMNew Delhi: Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications",...
Gufic Biosciences bags CDSCO approval to manufacture drug for severe fungal infections Ruchika Sharma27 April 2022 7:22 AMIsavuconazole for Injection 200 mg/vial is indicated for the treatment of patients who are 18 years of age and above.
Posaconazole as good as voriconazole for treatment of invasive aspergillosis: Lancet Medha Baranwal12 Feb 2021 5:00 AMDelhi: Posaconazole can be used as a first-line treatment for people with invasive aspergillosis, finds a recent study in the journal Lancet....
